Literature DB >> 18579226

The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: the role of inflammation.

Turgay Celik, Atila Iyisoy, U Cagdas Yuksel, Bekim Jata, Mustafa Ozkan.   

Abstract

The role of admission CRP levels on the prediction of poor myocardial perfusion grades after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI) has not been clearly elucidated. Dynamic nature of acute coronary syndromes is usually associated with spontaneous ischemia-reperfusion injury in infarct related artery. So we considered that poor myocardial perfusion after primary PCI is not only related to procedural factors and clinical characteristics of the patients but may also be related to microvascular damage starting before coronary intervention. We suggested that CRP mediated complement activation and neutrophil plugging may be the factors contributing to the development of microvascular damage in patients with AMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579226     DOI: 10.1016/j.ijcard.2008.03.058

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Yipin Zhao; Jiaojiao Yang; Yingying Ji; Shunli Wang; Tong Wang; Fengyun Wang; Jianmin Tang
Journal:  Heart Vessels       Date:  2019-04-16       Impact factor: 2.037

2.  MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans.

Authors:  Ming Zhang; Yunfang Joan Hou; Erdal Cavusoglu; Daniel C Lee; Rudi Steffensen; Liming Yang; Daniel Bashari; Jose Villamil; Motaz Moussa; George Fernaine; Jens C Jensenius; Jonathan D Marmur; Wilson Ko; Ketan Shevde
Journal:  Int J Cardiol       Date:  2011-12-15       Impact factor: 4.164

3.  Suppression of NF-κB reduces myocardial no-reflow.

Authors:  Min Zeng; Hongbing Yan; Yi Chen; Han-Jun Zhao; Yuan Lv; Cheng Liu; Peng Zhou; Bo Zhao
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

4.  MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Xin-Tao Zhang; Zhao-Rong Lin; Lin Zhang; Zi-Wen Zhao; Liang-Long Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-18       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.